XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Jan. 29, 2017
Jan. 31, 2016
Cash flows from operating activities:    
Net income $ 16,136 $ 13,333
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 5,304 4,888
Amortization of assets 162 123
Stock-based compensation 2,619 1,964
Excess tax benefit related to stock-based compensation (195) (822)
Deferred income taxes 3,533 1,906
Realized loss on sale of short-term investments 12 127
Gain on sale of equipment (71) (66)
Foreign currency exchange gains (18) (85)
Changes in assets and liabilities:    
Accounts receivable 340 1,091
Inventories (137) (6,485)
Other current assets 90 (108)
Other assets 51 48
Accounts payable - trade (946) (1,979)
Accrued expenses and deferred compensation (948) 1,406
Income taxes (1,695) 535
Net cash provided by operating activities 24,237 15,876
Cash flows from investing activities:    
Capital expenditures (9,253) (7,686)
Investment in unconsolidated joint venture (600)  
Proceeds from the sale of equipment 80 230
Payment on life insurance policy (18) (18)
Proceeds from the sale of short-term investments 2,000 5,612
Purchase of short-term investments (8) (86)
Purchase of long-term investments (Held-To-Maturity) (31,050)  
Purchase of long-term investments (Rabbi Trust) (1,431) (1,268)
Net cash used in investing activities (40,280) (3,216)
Cash flows from financing activities:    
Proceeds from line of credit 7,000 7,000
Payments on line of credit (7,000) (7,000)
Payments on vendor-financed capital expenditures (1,050)  
Payments on long-term debt   (2,200)
Excess tax benefit related to stock-based compensation 195 822
Repurchase of common stock   (2,397)
Dividends paid (5,292) (7,281)
Payments on debt issuance costs (2) (43)
Proceeds from common stock issued 37 138
Net cash used in financing activities (6,112) (10,961)
Effect of exchange rate changes on cash and cash equivalents 27 289
(Decrease) increase in cash and cash equivalents (22,128) 1,988
Cash and cash equivalents at beginning of period 37,787 [1] 29,725
Cash and cash equivalents at end of period $ 15,659 $ 31,713
[1] Derived from audited financial statements.